I hovered over the booking button for a couple of days, then when I went to do it they told me my invitation had been withdrawn due to lack of availability, not to contact my GP and they'd be in touch. I got the text again a few weeks later and jumped on it quicker that time.This post gives me some comfort, in that it confirms that i've not suddenly turned into an irrational hypocrite - I'm a mid 40s woman with a recent positive antibody test and i've not yet clicked to book my 1st jab, though it has been available to do since yesterday.
But also, I hadn't thought about the (obvious) fact that the people in this country who would have been most at risk - from a hesitant me - have already been vaccinated. So as you say, that does seem to reduce the urgency somewhat, I'm just thinking to hover over that booking button for another couple of weeks maybe see what changes. Feels pretty uncomfortable though, like i'm being silly, or selfish.
It's a fair point. You only know there's a surge after it's well under way. That's why I'm also in favour on balance of the mass testing programme.
I remain optimistic, though. We and certain other places like Portugal have already had the wave that is currently hitting places like Turkey. It will probably take a new mutation to cause another major outbreak here. And of course that could well happen, but it's not a certainty.
Denmark's just suspended the use of it outright. More for everyone else then.
Czechia: Waste not, want not.Denmark's just suspended the use of it outright. More for everyone else then.
Both vaccines are based on a new technology using adenoviruses, which cause the common cold, that have been modified to essentially render them harmless. The viruses are employed as vectors to ferry instructions for human cells to make proteins found on the surface of the coronavirus, priming the immune system to make antibodies that fight off the actual virus.
Scientists are working to find the potential mechanism that would explain the blood clots. A leading hypothesis appears to be that the vaccines are triggering a rare immune response that could be related to these viral vectors, FDA officials said at a briefing on Tuesday.
Greinacher noted that there have been discussions on the possibility that the rogue antibody is produced by the immune response to the virus spike protein in the vaccine (the wanted protective immune reaction of the vaccine), as the structure of part of the spike protein resembles part of the PF4 molecule. But evidence thus far suggests that this is not a cross-reacting antibody.
"That is fantastic news for the vaccine program as it would have meant that all vaccines would have been affected," he commented.
On whether the reaction could be caused by the adenoviral vector used in the AstraZeneca vaccine, Greinacher says it is "too early for a reasonable scientific argument to be drawn on a direct link. We know that adenovirus interacts with platelets, so in theory that could make sense. But if this was the mechanism, I would have expected many more patients to have had these problems."
In the NEJM paper, Greinacher et al add: "The amount of adenovirus in a 500 microliter vaccine injection administered 1 or 2 weeks earlier would seem unlikely to contribute to subsequent platelet activation observed in these patients."
I don't know if anyone can help with this, just a question.
My friend who had a stroke 3 years ago, he's due to get 2nd jab of AZ on Tuesday this coming week.
On 7th April, the MRHA was saying this .View attachment 267275
I can't find anything more recent and seems to be absent from the nhs website that advice now.
Maybe they have changed their view on this in the past month, it looks like it.
Should he at least speak to his gp at least first? he's 41.
I wonder if "us younguns" will be getting Moderna or Pfizer then? Not sure which they have more left of at the moment...
Tbh id probably have AZ no bother, but having a posh/expensive one is a bit of a bonus I wonder whether it'll be massively inconvenient tho... no way do I want to travel to a different town or city for a jab right now.
I'm going to be in danger of sounding like a naggy parent and appreciate not everyone has access to a car but at a time when vast swathes of the global population don't have any access to a vaccine you've not only got access to one but are being given a choice of vaccine. It seems a bit millennial to be bothered that you might be inconvenienced by having to travel a bit.
Well tbf you dont know my circumstances. Not only do I not have a car I can barely walk 10 mins down the road. And yes there is always someone worse off, that's the nature of life sadly.
Frankly id rather have AZ than get sent off on a car trip to somewhere 45 mins away.
Frankly id rather have AZ than get sent off on a car trip to somewhere 45 mins away.
A friend of mine who lives in Oxford was initially only offered an appointment at Stoke Mandeville or Heathrow. After a few days of looking he got an appointment at the Oxford Utd** stadium
Just got this through work email bimble
Questions re: previous blood clot with AstraZeneca
There has been some confusion regarding the rationale for asking whether an individual has had a previous blood clot when screening for the AstraZeneca vaccine. This is to rule out whether the individual has a history of heparin-induced thrombocytopenia and thrombosis (HITT or HIT type 2) or has experienced major venous and/or arterial thrombosis occurring with thrombocytopenia following vaccination with any COVID-19 vaccine. As the majority of patients would not necessarily know they had thrombocytopenia we ask whether they have had a clot and if they say yes it should be followed up with do you know the cause?
If the patient indicates something unrelated to the 2 indications above such as a long haul flight or a fall then it is ok to administer. If in doubt check with the clinical lead. There is no evidence that those with a prior history of thrombosis or known risk factors for thrombosis are more at risk of developing the reported serious thromboembolic events with concurrent thrombocytopenia after the COVID-19 Vaccine AstraZeneca. For most of these individuals, the risk of recurrent thrombosis due to COVID-19 infection remains far greater than the risk of this syndrome.
The paragraph says this, it is talking about thrombus post-vaccine, but it's only ones with HITTS 1 or 2 that are concerning, not just any clots which are common.
"This is to rule out whether the individual has a history of heparin-induced thrombocytopenia and thrombosis (HITT or HIT type 2) or has experienced major venous and/or arterial thrombosis occurring with thrombocytopenia following vaccination with any COVID-19 vaccine."
AFAIK if you've had a clot with HITT post first dose of AZ then you don't get a second dose of AZ, but I have no idea what people are getting (if anything) as I've not come across it and it wouldn't be something I would, nor would I deal with making the decision.
The other condition that makes it not possible to get any AZ vaccine is Antiphospholipid syndrome (APS)
Is it known how rare (or not?) are the above conditions?
Apologies for being unclear, and in a pre-work hurry.
I was trying to ask about the two particular conditions you specified in your previous post.
I suppose that comparing the general rarity and the post vaccination rarity of them might? be interesting too.